Back to Search
Start Over
Movement disorders associated with withdrawal from high-dose intravenous haloperidol therapy in delirious ICU patients.
- Source :
-
Chest [Chest] 1997 Jun; Vol. 111 (6), pp. 1778-81. - Publication Year :
- 1997
-
Abstract
- Intravenous haloperidol is recommended as the drug of choice to treat delirium in ICU patients. Movement disorders and other adverse events commonly occur with oral haloperidol use but are rarely seen with IV haloperidol use, and withdrawal symptoms have not been reported with short-term ICU use. We describe self-limited dyskinesia during withdrawal of high-dose continuous IV haloperidol therapy in five ICU patients.
- Subjects :
- Adult
Delirium drug therapy
Dyskinesia, Drug-Induced diagnosis
Female
Haloperidol administration & dosage
Humans
Infusions, Intravenous
Male
Middle Aged
Time Factors
Critical Care
Delirium complications
Dyskinesia, Drug-Induced etiology
Haloperidol adverse effects
Substance Withdrawal Syndrome diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 0012-3692
- Volume :
- 111
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Chest
- Publication Type :
- Academic Journal
- Accession number :
- 9187213
- Full Text :
- https://doi.org/10.1378/chest.111.6.1778